DNMT1 and acute myeloid leukemia: In this study, we first demonstrated that the hydroxamic acid HDAC inhibitor, SAHA, as well as the cytidine analogue DNMT inhibitor, DAC, attenuates the proliferation of AML cell lines KG-1 and U937, in vitro.